Produced by:
|
Hosted by:
|
Premier Media Sponsor:
|
Media Sponsors:
|
Home |
Register Now |
Conference at a Glance |
Workshop Agenda - 05/13 |
Conference Day 1 - 05/14 |
Conference Day 2 - 05/15 |
Sponsor & Exhibitor Info |
Accommodations |
Exhibitors |
Other Events
Conference Day Two
Wednesday, May 15, 2002*
|
| 8:00am - 9:00am |
Registration
|
| 9:00am - 10:00am |
Keynote II - Nanotechnology: Near And Long Term Possibilities
Nanotechnology will let us inexpensively arrange atoms in most of the ways permitted by physical law. This will revolutionize manufacturing, opening the door to new ultra light and ultra strong materials, computers orders of magnitude more powerful than anything that exists today, molecular medical tools that will usher in a revolution in medicine, and a host of other remarkable products. What are the possibilities, when can we expect them, and how do we make it all happen?
Dr. Ralph Merkle, Vice President, Technology Assessment, Foresight Institute
|
| 10:00am - 10:30am |
Morning Break/Exhibit Hall Opens
|
| For the remainder of the day, attendees may choose between three topics - Life Sciences, Nanoelectronics or Nanomaterials. Further information on each track is provided below. Switching between tracks throughout the course of the day is allowed.
|
Life Sciences Track
|
| The life sciences encompass a vast set of disciplines including biology, biochemistry, biotechnology, genetics, and multiple other specializations. This track of sessions examines the intersection of nanotechnology and life science. Near and long-term commercialization potential is explored in these sessions. Case study companies discuss their own business development strategies and also explain their products, markets and end-uses.
|
| 10:30am - 11:30am |
How VCs Identify & Work With Nanotech Companies
Over 50 investment firms have nanotechnology in their portfolios. This special panel investment panel provides insights on senior investors' perspectives on the nanotechnology startup sector. The panel discusses exactly how investors identify promising emerging nano-companies and commercialization opportunities. The challenges of adding value to early stage companies transitioning into a full-scale business setting and the challenges and tasks faced by investors when transitioning academics into a business mode is also discussed. For nanotechnology startups or aspiring startups, this is one session you won't want to miss.
Moderator:
Sandra Kay Helsel, Ph.D., Managing Editor, NanotechPlanet.com and Conference Program Chair, NanotechPlanet Conference and Expo
Panelists:
Dr. Raouf O. Loutfy, COO, MER Corporation
Rob Miles, General Partner, Vortex Partners
Ajay Ramachandran, General Partner, Ark Venture Partners
Zwi Vromen, Director, Managing Partner, Millenium Materials Technologies Fund
|
| 11:30am - 12:30pm |
Nanoparticle Technology-Enabled Drug Delivery
Poorly water-soluble compounds, which represent upwards of 60% of discovery compounds, are difficult, if not impossible, to develop as drug products using conventional formulation techniques and are frequently abandoned in the early discovery stage. NanoCrystal™ technology offers an opportunity to formulate these problematic compounds and address their deficiencies to increase the number of products developed for oral, intravenous, intramuscular, subcutaneous and pulmonary routes of administration. This session provides the fundamentals and benefits of this nanotechology with several illustrative examples.
Dr. Gary G. Liversidge, Sr. Director of Project Leadership and Management, Elan Drug Delivery, Inc.
|
| 12:30pm - 2:00pm |
Lunch Break/Visit Exhibit Hall
|
| 2:00pm - 3:00pm |
Case Study: How Nanotechnology May Affect the Course of Medicine
In this session, a pioneer company describes how it has
developed nanotechnology to address unmet medical needs for life-threatening diseases, and how it has met the challenges of developing protein engineered chemotherapy-laden nanoparticles for the treatment of cancer. Companies working to develop nanotech-enabled delivery technologies for drug, cell and gene therapy must address the difficult business development processes faced by biotechs: intellectual property protection, commercialization of research, regulatory FDA rules and lengthy R&D processes. In this session, this company will describe how it has successfully met early challenges in this cutting-edge field , and brought a nanotechnology from lab bench discovery to late-stage human clinical trials in breast cancer .
Patrick Soon-Shiong, M.D., Founder, Chairman, CEO and President, American Pharmaceutical Partners (APP)
|
| 3:00pm - 3:30pm |
Afternoon Break
|
| 3:30pm - 4:00pm |
SPECIAL SESSION: Commercialization Of Nanotechnology At NASA Ames Research Center
NASA Ames Research Center, situated in the heart of Silicon Valley, is developing Nanotechnology for space mission applications. This session addresses the efforts of the Commercial Technology Office to identify, patent, and commercialize promising nanotechnology innovations in applications ranging from medical diagnosis to advanced materials.
David I. Lackner, Technology Commercialization Manager, NASA Ames Research Center
|
| 4:00pm - 4:30pm |
Investments In Nanotechnology
The Defense Advanced Projects Agency (DARPA) is one of the US Federal Agencies sponsoring research and development as part of the National Nanotechnology Initiative (NNI). It is important to realize that the NNI involves almost all the US Agencies that sponsor R&D. Thus the NNI can be viewed as an umbrella for funding research at the forefront of fields across the hard and soft sciences. It should also be noted that the significant budgets now being dedicated to the NNI are not all 'new' money. In many cases they represent a redirection of existing budget lines. The largest participants, in dollar terms, in the NNI are the DoE, DoD and NSF. However, they have rather different investment priorities. For example, the NSF and DoD are predominantly sponsoring university based research and centers whereas the DoE is making significant investments into the infrastructure of its in-house Labs.
In keeping with the diverse nature of Nanotechnology, the specific projects supported by DARPA range across a variety of technical disciplines including the hard and soft sciences. However, in contrast to other funding agencies, DARPA's projects are goal driven and have a finite duration of, typically, 4 years. Broadly speaking, DARPA projects can be described as 'Technology Push' or 'Application Pull'. Our current Nanotechnology projects clearly fall under the former category. Nonetheless, technology transition is an integral part of all of our projects, and those in the area of Nanotechnology are no exception. In the case of programs, such as Molecular Electronics and Nanoimprint Patterning, transitions have predominantly been into the commercial sector through start-up companies who have licensed IP developed under DARPA sponsorship. While it is still early days, there is a high level of optimism and enthusiasm associated with these start-ups.
Christie R.K. Marrian, Microsystems Technology Office, Defense Advanced Projects Agency (DARPA)
|
| 4:30pm - 5:00pm |
How Small Objects Can Lead To Environmental & Health-Related Opportunities
This session covers three areas in which nanoscience will have huge impact: water desalination, biological integration and energy efficient cooling technologies. These nanotechnologies promise to help alleviate many environmental and health-related issues. Rather than exploiting nano-objects to solve these issues, the largest impact of nano-technologies is when they are embedded in a micro/macro system in a seamless fashion. Attendees will walk away from this session with a new understanding for nanotechnology and the impact it will have on every aspect of our environment and workspace.
William Warren, Ph.D., Sciperio, Inc.
|
Nanoelectronics Track
|
| Modern civilization runs on a complex electronic infrastructure. This track of sessions first examines the scientific intersection of nanotechnology and electronics, including optics. Near and long-term commercialization potential is explored in these sessions. Case study companies discuss their business development strategies and also explain their products, markets and end-uses.
|
| 10:30am - 11:30am |
Commercialization Of Nanotechnology Projects At Yale
The Mark A. Reed Research Group at Yale is well respected for its work in Molecular Electronics, Semiconductor Devices, MEMS, bioMEMS, Carbon Nanotubes and Quantum Devices. This speaker discusses this research and also explain how it led to commercialization of two projects.
James Klemic, Ph.D., Mark A. Reed Research Group, Yale University
|
| 11:30am - 12:30pm |
Case Study: Building a Nano-Electronics Products Businesses
This session provides a case study discussion from a leading R&D nanotechnology company focused on the development of nano-electronic products such as AFM nanoprobes, FED, sensors and biochips.
Xihong Deng, CEO, Molecular Nanosystems
|
| 12:30pm - 2:00pm |
Lunch Break/Visit Exhibit Hall
|
| 2:00pm - 3:00pm |
SPECIAL SESSION - Stanford Office Of Technology Licensing: Turning Scientific Progress Into Tangible Products
This presentation highlights one of the world's foremost programs for turning scientific research into tangible products. Particular attention will be paid to nanotechnology research and licensing strategies, including technical and market risks.
Katherine Ku, Director, Office of Technology Licensing, Stanford University
|
| 3:00pm - 3:30pm |
Afternoon Break
|
| 3:30pm - 4:30pm |
MEMS: Pushing Down To The Nanometer Scale
MEMS technology has been talked about and explored for more than the past twenty years and is just now surfacing as its own industry. Many of the fabrication techniques are still formative, with very few being able to be exploited on the commercial front. This session provides a technical overview of Standard MEMS, Inc.'s fabrication processes and a technical road map of what SMI intends to focus on in order to push its MEMS processes down to the nanometer scale.
Nicholas E. Ortyl, President, Chief Executive Officer and Chairman, Standard MEMS, Inc.
|
| 4:30pm - 5:00pm |
Recruiting Talent In Nanotechnology Now & Into The Future
Many potential investors, entrepreneurs and executives are concerned that there will be a serious shortfall of talent in nanotechnology in the not-too-distant future. Estimates have been made that there are only 25,000 nanotechnology scientists in the U.S. now, and only 800 new postgraduates a year entering the field. A lack of scientific expertise could have a chilling effect on growth and investment in nanotechnology. This session outlines current "nanotalent" needs and explains specifically why there is a problem and how to address it. Future talent outlook and ways to plan for future headcount growth also are discussed.
Herman Collins, CEO, NanoOptic Networks
|
Nanomaterials Track
|
| The Materials Sciences furnish the building blocks of modern manufacturing. Nanomaterials are materials whose microstructural building blocks have been precision engineered to fall below 250 nanometers, preferably sub-100, on the nanometer scale. This track of sessions examines the intersection of nanotechnology and materials sciences. Near and long-term commercialization potential are also explored in these sessions. Case study companies discuss their business development strategies and also explain their products, markets and end-uses.
|
| 10:30am - 11:30am |
Building A Business In The Carbon Nanotube Sector: A Success Study
This speaker will first describe nanotubes, the thinnest tubes made of a rolled-up sheet of carbon atoms. Nanotubes offer vast potential for the generation of new compounds with enhanced qualities. In this session, nanotube applications, such as flat-panel displays and EMI/RFI shielding, are discussed. The presenter also discusses his company's business development strategies such as strategic partnering or integration with existing industries, and financing successes to-date.
Thomas G. Pitstick, Business Development, Carbon Nanotechnologies, Inc.
|
| 11:30am - 12:30pm |
SPECIAL SESSION - Microscopy: Technology Overview & Market Outlook
This session provides an overview of the characteristics of common microscopic technologies used today for imaging and measuring surface morphology. Speakers describe Scanning Tunneling Microscopes, Atomic Force Microscopes and other types of Scanning Probe Microscopes. This session also provides an analysis of projected market development paths of nanotechnology and microscopy. This session also provides an analysis of projected market development paths of nanotechnology and microscopy.
Steve Lenhert, Chief Scientific Officer, QuaNTeQ, LLC
|
| 12:30pm - 2:00pm |
Lunch Break/Visit Exhibit Hall
|
| 2:00pm - 3:00pm |
Supportive Instrumentation
Instrumentation supportive to nanotechnology research and development is one arena already being used to sell hard products. This session provides a look at the varied instruments available and their individual uses. Speakers give estimations of market growth.
Katerina Moloni, Ph.D., Vice President, Marketing, PIEZOMAX Technologies
Doug Schiff, VP, Marketing & Business Development, 3rdTech
|
| 3:00pm - 3:30pm |
Afternoon Break
|
| 3:30pm - 4:30pm |
A Visionary Predicts: Nanotechnology Is The Gateway To An Entire New Industrial Infrastructure
Nanotechnology is rapidly evolving away from the realm of academic obscurity and becoming the transitional threshold of an emergent industrial revolution. This speaker addresses his vision of the coming nanoindustrial infrastructure development and its significant economic implications including the products, processes and applications that are not possible via any other manufacturing means.
Charles Ostman, Senior Fellow, Institute for Global Futures
|
| 4:30pm - 5:00pm |
Case Study: Nanotechnology In The Textile Industry
This session describes how an advanced materials company is using proprietary nanotechnology to create, change and improve textiles at the molecular level. The presenter also describes how the company is leveraging assets held by its partners and suppliers to maintain a level of profitability. This session will also address how to create a business model that is readily scalable to meet global competition.
Moderator
David Soane, Chief Scientific Officer, Nano-Tex, LLC.
Panelist
Dan Millward, Ph.D., Director of Advanced Chemistry, Nano-Tex, LLC.
|
|
